# WS-0015 VALUATION-0007 Stage-4 Equity Valuation Execution — Implementation Audit

**Date:** 2026-08-10
**Authority:** `governance/decisions/VALUATION-0007-equity-valuation-execution-authorization.md` (merged via PR #290, merge SHA `adeec3acb9986b1de08c2116b23cdfe20addf07b`)
**Scope:** Populate real `intelligence/valuation_results/<TICKER>.yaml` records for the 27-name canonical equity cohort under the already-governed `VALUATION-0002`/`VALUATION-0006` methodology and `valuation_result_validator.py` schema (unedited).
**Author:** this session (Claude Sonnet 5), sole mutation lane.

This document is the retained narrative record of what was actually done, why, and what the results honestly mean and do not mean. It is written for a future independent reviewer who has not seen this session's own reasoning.

---

## 1. Starting-state verification

Before any mutation, this session independently re-verified (not assumed from the authorizing task):

- `HEAD` == `origin/main` == expected merge SHA `adeec3acb9986b1de08c2116b23cdfe20addf07b`.
- PR #290 (`VALUATION-0007` governance filing) confirmed merged: `merged: true`, head `169231abf0622e68dc4d5ffea4df30da3d2c2fc8`, merge commit `adeec3acb9986b1de08c2116b23cdfe20addf07b`.
- Zero open pull requests.
- `intelligence/valuation_results/` absent from the repository.
- `valuation_result_validator.py` / `test_valuation_result_validator.py` present, both from the merged `VALUATION-0006` Stage-4 scaffold.
- 27-name canonical equity cohort independently re-derived from live `targets.yaml` (`asset_class: equity` rows) and cross-checked against the sealed `valuation_archetype`/`valuation_evidence` cohorts (27/27, zero drift on all three).
- Baseline suite state reproduced: `test_portfolio_hq_dashboard_decisions.py` 95 passed; full `pytest` 4215 passed, 0 failed; decision catalog 104 decisions, 0 issues; all 11 pre-existing validators clean; repo-wide YAML/YML 207 files / 0 errors, JSON 178 files / 0 errors.

## 2. Controlling authority read in full before drafting

`VALUATION-0002` (methodology-role doctrine, the 7×7 governed-role table, the four-label assumption-provenance vocabulary), `VALUATION-0003` (archetype-assignment precedent and batching discipline), `VALUATION-0004`/`VALUATION-0005` (the Stage-3 evidence schema and its actual population), `VALUATION-0006` (the Stage-4 application policy: methodology-family compatibility, terminal-growth hard rule, range-not-point requirement, peer/scenario subset rules, conflict-propagation live cross-check, closed `result_status` vocabulary, targeted isolation for peer/scenario/terminal-growth judgments), `VALUATION-0007` (this execution authorization, its four method-homogeneous batches, and its seven disclosed cohort limitations), `TIER-0009` §K (states plainly that no valuation framework existed before this program and that `target_and_range`/`maximum_position_size` remain `valuation_required` regardless of this implementation's own output), `valuation_result_validator.py` in full (all ~1,850 lines), and all 27 sealed `valuation_archetype`/`valuation_evidence` records via direct inspection and a programmatic extraction pass (financial figures, segment data, peer identities, scenario names, discount-rate/segment/market abstentions, disclosed conflicts).

## 3. Methodology design (why every family entry looks the way it does)

**The load-bearing finding, established before any record was drafted:** Stage-3 evidence (`peer_set_evidence`) carries only peer *identity* and *comparability rationale* — never a peer's own financial figures or trading multiple. No ticker in the 27-name cohort has a real, sourced peer multiple available anywhere in this repository. Combined with `discount_rate_evidence`'s universal abstention (confirmed programmatically: 27/27), this means **no methodology family in this cohort can be computed from a genuinely peer-derived or discount-rate-derived input.** The only two paths that remain evidence-grounded are (a) the company's own real reported/derived financial figures (revenue, earnings, FCF, segment revenue/profit, share count, cash, debt) and (b) a disclosed, honestly-labeled **illustrative** multiple assumption (`provenance_label: assumed_for_illustration`) — exactly the fourth label `VALUATION-0002` §3 exists to sanction for precisely this situation.

Given that, this implementation adopted one consistent design across all three quantitative family types used (`family_5` relative valuation, `family_1` SOTP, `family_7` scenario):

- **Real, evidence-sourced base metric.** Every `low`/`base`/`high` value is built from a real reported or derived Stage-3 financial figure (net income, FCF, segment revenue/profit, revenue-per-share) — never an invented dollar figure.
- **Illustrative, not market-anchored, multiple.** The multiple bands are deliberately **not** anchored to the ticker's own current market price. Two reasons: (1) a market-anchored multiple (price ÷ EPS, restated as "base") is tautological — it doesn't independently value anything, it just reproduces the observed price; (2) it would have made the current market price a silent input, which is unnecessary and would have blocked several tickers with missing or abstained price data (GOOGL, SNPS, GEV) for a reason that has nothing to do with genuine evidence insufficiency. Illustrative multiples let the methodology proceed on real fundamentals wherever they exist, independent of whether a current price happens to be in evidence.
- **Multiple bands are archetype-differentiated, not per-ticker-invented,** and their selection rationale is stated once per archetype/family combination (e.g., "asset-light platform archetype A: P/E 24-30-38"; "capital-intensive infrastructure archetype B: P/E 15-19-24"; SOTP segment tiers keyed to disclosed segment operating margin where available, else the company's own overall margin as a proxy). No number was picked to make a particular ticker look better or worse.
- **Every range is honestly presented as a sensitivity band, never a fair-value opinion.** Every record's `governing_sensitivity`/`sensitivity_disclosure`/`uncertainty_summary` states this explicitly and states that the range is not a comparison to (nor a claim about) the current market price. No record anywhere uses "undervalued"/"overvalued" framing or any of the validator's forbidden recommendation-shaped phrases (mechanically confirmed — see §7).

This design is disclosed, not hidden, in every single record.

## 4. Per-ticker methodology and result-status distribution

**Result-status distribution: 18 `completed`, 9 `partial`, 0 `unable_to_determine`.**

| Ticker | Archetype | Family applied | Governed role | Family status | Overall result_status |
|---|---|---|---|---|---|
| AMZN | F | 1 (SOTP) | primary | completed | **completed** |
| ASML | B | 5 (relative) | primary | completed | **completed** |
| AVGO | F | 1 (SOTP) | primary | completed | **completed** |
| CEG | B | 5 (relative) | primary | completed | **completed** |
| COST | G | 5 (relative) | secondary | completed | **completed** |
| ETN | F | 1 (SOTP) / 5 (relative) | primary / adjustment | unable_to_determine / partial | **partial** |
| GEV | B | 5 (relative) | primary | partial | **partial** |
| GNRC | D | 7 (scenario) | primary | partial | **partial** |
| GOOGL | F | 1 (SOTP) | primary | completed | **completed** |
| ICE | C | 5 (relative) | adjustment | partial | **partial** |
| ISRG | A | 5 (relative) | primary | completed | **completed** |
| KLAC | D | 7 (scenario) | primary | partial | **partial** |
| LLY | A | 5 (relative) | primary | completed | **completed** |
| META | A | 5 (relative) | primary | completed | **completed** |
| MSFT | F | 1 (SOTP) | primary | completed | **completed** |
| NVDA | A | 5 (relative) | primary | completed | **completed** |
| PANW | A | 5 (relative) | primary | completed | **completed** |
| PWR | B | 5 (relative) | primary | partial | **partial** |
| RKLB | E | 7 (scenario) | primary | partial | **partial** |
| RTX | F | 1 (SOTP) | primary | completed | **completed** |
| SNPS | A | 5 (relative) | primary | completed | **completed** |
| SPGI | F | 1 (SOTP) | primary | completed | **completed** |
| TMO | G | 5 (relative) | secondary | completed | **completed** |
| TSLA | F | 1 (SOTP) | primary | completed | **completed** |
| TSM | B | 5 (relative) | primary | partial | **partial** |
| V | C | 5 (relative) | adjustment | partial | **partial** |
| WM | B | 5 (relative) | primary | completed | **completed** |

`family_2`/`family_3` (FCFF/FCFE DCF) were **not applied to any ticker in the cohort** — `discount_rate_evidence` is abstained on all 27 sealed Stage-3 evidence records, so no discount rate, WACC, beta, or terminal growth rate was fabricated anywhere. Every record's `uncertainty_summary` states this explicitly (see §5).

## 5. Universal DCF / discount-rate limitation

Confirmed programmatically before drafting began: `discount_rate_evidence.abstention_reason` is non-empty on all 27 sealed Stage-3 evidence records. Under `VALUATION-0006`'s own compatibility table, family 2 (FCFF DCF) and family 3 (FCFE DCF) are `primary_candidate` for archetypes A and G — meaning the doctrine-Primary path for 8 of the 27 tickers (ISRG, LLY, META, NVDA, PANW, SNPS, COST, TMO) is a family this implementation could never bring to `completed` even in principle, given the current evidence base. This is stated verbatim, per ticker, in every one of the 27 records' `uncertainty_summary` field. No record anywhere populates a `terminal_growth`/`applicable_discount_rate` pair, an ERP, a beta, or a WACC value. Closing this gap (populating real discount-rate-component evidence) is explicitly out of this implementation's scope and remains a separate, future, unauthorized governance unit.

## 6. Named cohort limitations, resolved as instructed

- **ETN** — `segment_evidence` is domain-abstained (zero segments), which is `family_1`'s (SOTP, ETN's sole primary-candidate family for archetype F) required domain. `family_1` is recorded as `family_status: unable_to_determine` with `valuation_range: null`, explicitly documenting the blocked primary path. A corroborative-only `family_5` (relative valuation, `adjustment_required` for archetype F) was attempted using ETN's real, clean net income/share-count/peer data, reaching `family_status: partial` — capped by governed role, never by data quality. Overall `result_status: partial`.
- **TSM** — only one included peer (`ASML`) exists in Stage-3 evidence, below `VALUATION-0006` §C item 11's two-peer floor for `family_5`'s `completed` status. `family_status: partial` regardless of otherwise-clean underlying data (TSM's own net income required derivation from its disclosed net margin applied to its USD-equivalent revenue, since TSM's reported net income exists only in TWD in Stage-3 evidence — disclosed explicitly).
- **PWR** — `financial_evidence`'s FY2025 `earnings` line item carries a disclosed conflict (two irreconcilable diluted-EPS figures, $6.80 vs $6.91). "earnings" is one of `family_5`'s own `_FAMILY_RELEVANT_ITEM_CATEGORIES`, so this mechanically blocks `family_status: completed` for PWR's `family_5` regardless of which specific figure this record's own computation actually used (the aggregate net income figure, $1,030M, is independently corroborated and not itself disputed — the validator's category-level rule still applies, exactly as designed, and this record does not attempt to route around it). A `conflicts_carried_forward` entry (`domain: financial_evidence`, `pointer_type: disclosed_conflict`) is present. `family_status: partial`.
- **ICE / V** — archetype C (regulated financial-market infrastructure) reaches no `primary_candidate` or `secondary_corroborative` family anywhere in `VALUATION-0002`'s governed-role table; every family is either `prohibited` or `adjustment_required`. `family_5` was still attempted for both, using clean real data (net income, share count, 3 included peers each), reaching `family_status: partial` — structurally incapable of `completed` under current doctrine, independent of evidence quality. This is `VALUATION-0007`'s own explicitly disclosed, expected outcome for this archetype.
- **GNRC / KLAC** — each has exactly one named scenario in Stage-3 evidence (no upside/downside/base decomposition). A genuine probability-weighted methodology needs multiple weighted outcomes to be meaningful; with only one, this implementation offers a single illustrative outcome value (no `probability_weight` populated, `scenario_set_is_exhaustive: false`), `family_status: partial`.
- **RKLB** — the richest scenario base in the cohort (3 real, evidence-grounded named scenarios). FY2025 net income (-$198.2M) and free cash flow (-$321M) are both negative, so a P/E or FCF-yield approach is not meaningful; revenue-per-share with illustrative Price/Sales-style multiples per scenario was used instead. Probability weights (0.30/0.30/0.40, summing to 1.00) are this session's own freshly-assigned execution-time judgment — **not** sourced from Stage-3 evidence, which names the scenarios and their qualitative basis only, never a probability. `family_status: partial` — the weights' own lack of evidentiary grounding is the reason, disclosed explicitly, not a data-quality problem with the underlying scenario evidence.
- **GEV** — capped at `partial` by disclosed judgment, not by a mechanical validator rule: only one fiscal period of `financial_evidence` exists (no multi-year trend, unlike every other ticker in the cohort), and two of six evidence domains (`segment_evidence`, `market_observed_evidence`) are abstained. `family_5` mechanically satisfies the two-peer floor (`ETN`, `PWR` both included) but this record deliberately declares `partial` anyway given how much thinner GEV's overall evidence base is relative to the rest of the cohort — an honest, disclosed judgment call, not a validator-forced outcome.

## 7. Targeted-isolation compliance (`VALUATION-0006` §O)

The three protected judgments — applied-peer-set selection (not exercised: no ticker's `applied_peers` list required choosing among more candidates than were used; every included peer named in Stage-3 evidence was cited as comparability context), scenario-probability assignment (RKLB), and terminal-growth selection (not exercised: no `terminal_growth`/`applicable_discount_rate` pair was ever populated anywhere in the cohort, per §5) — were made without consulting or citing `portfolio_role_ref`, `conviction.rating`, `target_pct`, current holding size/status, the Milestone-8 recommendation disposition, or `gates.yaml` status for any ticker. Every record whose `governing_sensitivity` text touches one of these three judgments states this compliance explicitly (see e.g. `RKLB.yaml`, `GNRC.yaml`, `KLAC.yaml`). This session did not open `targets.yaml`, `holdings.yaml`, `gates.yaml`, or `intelligence/recommendations/` at any point while drafting family content — confirmed by this session's own tool-call history.

## 8. No portfolio-policy leakage — mechanically confirmed, not merely asserted

`valuation_result_validator.py`'s own independent free-text scan (forbidden recommendation-shaped phrases, word-boundary-matched directive/trading language, chart-domain terminology) and forbidden-key-name scan (opaque fair-value/price-target/composite-score fields, equity-classification/archetype-layer leakage, ETF/crypto-classification leakage, numeric score/rank/target-key leakage, allocator/margin-coupling leakage) ran clean against all 27 records — `valuation_result_validator: OK (28 result(s))`. This session additionally ran an independent, word-boundary-correct manual grep for the same term classes as a second check; the only apparent hits were the substring "stage" inside "Stage-3" (this repository's own established evidence-layer terminology), which the validator's own disclosed legitimate-use whitelist already scrubs before the bare-word check — confirmed by direct inspection of `_DIRECTIVE_LEGITIMATE_USE_PATTERNS["stage"]`. No genuine leakage exists anywhere in the 27 records or the manifest.

## 9. Manifest / hash reconciliation

27/27 records sealed with `record_status: sealed` and all five required seal fields. `COHORT_MANIFEST.yaml` carries one row per ticker with `content_sha256` matching both (a) the value independently recomputed via `valuation_result_validator.canonical_record_hash()` and (b) the record's own stored `content_sha256` field — verified bidirectionally, zero mismatches, zero orphans (`validate_cohort_manifest` passes clean). A dedicated determinism check (recompute every record's hash from its own on-disk content and compare to the stored value) found zero mismatches across all 27. `validate_authorized_cohort()` against the exact 27-name `VALUATION-0007` population returns valid with zero missing/extra tickers.

## 10. Validator/test change and why

No change to `valuation_result_validator.py` — the existing schema and compatibility rules were sufficient for every family/status combination this implementation needed; no genuine implementation defect was found.

`test_valuation_result_validator.py`'s `TestPopulationAndLifecycle` class carried two tests asserting the Stage-4 scaffold's zero-population state (`test_absent_result_directory_accepted_at_scaffold_state`, `test_zero_real_company_population_in_repository`) — accurate for the scaffold PR #290 authorized, made false by this implementation's own authorized population. These two tests were replaced with five tests asserting the positive invariant instead (directory exists with exactly the 27-name authorized cohort; manifest committed and reconciles; the validator module itself still hardcodes no population — `AUTHORIZED_POPULATION`/`DEFAULT_TICKER` both absent; a full directory scan returns the expected 28 results — 27 records + 1 manifest; `validate_authorized_cohort()` passes against live state) — mirroring, field-for-field, the identical `TestAuthorizedCohortPopulation` precedent `valuation_archetype_validator.py`'s and `valuation_evidence_validator.py`'s own prior population implementations already established for exactly this situation. Net effect: 176 tests in this file (up from 173), 5 added, 2 removed. No test was weakened — every removed assertion tested a state this implementation was itself authorized to end.

## 11. Full validation results

- `valuation_result_validator.py` standalone: `OK (28 result(s))`.
- `test_valuation_result_validator.py`: 176 passed, 0 failed.
- All 11 other pre-existing repository validators: clean and unaffected (`classification_validator` 28, `reconciliation_validator` 27, `recommendation_validator` 27, `relationship_validator` 13, `intelligence_validator` clean, `freshness_validator` OK, `contender_registry_validator` 84, `etf_classification_validator` 5, `crypto_classification_validator` 4, `valuation_archetype_validator` 28, `valuation_evidence_validator` 28).
- Full repository `pytest`: **4218 passed, 0 failed** (4215 pre-existing baseline + 3 net new tests, exact match).
- `test_portfolio_hq_dashboard_decisions.py`: 95 passed — decision catalog unaffected (104 decisions, 0 issues) — no new governance decision filed by this implementation.
- Repo-wide YAML/YML parsing: 235 files (207 baseline + 28 new), 0 errors. JSON parsing: 178 files, 0 errors.
- `git diff --check`: clean.
- Protected-path scan: zero diff on `targets.yaml`, `holdings.yaml`, `gates.yaml`, `issuer_lookthrough.yaml`, `allocate.py`, `margin_state.py`, `levels.py`, `valuation_result_validator.py`, every existing `intelligence/{classification,companies,themes,relationships,reconciliation,recommendations,contenders,etf_classification,crypto_classification,valuation_archetype,valuation_evidence}/` record, every `governance/decisions/*.md`, `PROTOCOL_V1.md`, `METHODOLOGY_EVALUATION_REPORT.md`, `docs/PORTFOLIO_INTELLIGENCE_SPEC.md`.
- Zero import coupling with `allocate.py`/`margin_state.py` in either direction (unchanged — this implementation touches no Python module beyond the test file described in §10).
- Exact changed-file inventory: `intelligence/valuation_results/` (27 sealed records + `COHORT_MANIFEST.yaml` = 28 new files), `test_valuation_result_validator.py` (modified), this retained audit (new), `operations/WORKSTREAMS.yaml` (Lane-M fold-forward + new gate), this `CLAUDE.md` entry (new) — no `governance/decisions.yaml` change, since no new governance decision is filed by this implementation.

## 12. What this implementation does not do

It does not resolve `TIER-0009` §K's `valuation_required` status for `target_and_range`/`maximum_position_size` on any of the 27 equities — every result record is evidence output for later governance, not a portfolio decision. It does not compute, cite, or imply a fair value, price target, expected return, buy/sell/hold/trim/exit signal, opaque score, rank, or target weight for any ticker. It does not change any tier, target, holding, gate, cap, cluster, allocator, margin, ladder, or chart-evidence state. It does not authorize any `CONTENDER-0003`, ETF, crypto, or cross-asset work. The 27-company cohort remains a bounded first equity-valuation population, not the exhaustive Portfolio-HQ contender universe (26 already-researched non-canonical Company Intelligence contenders, and the broader 84-entry contender registry, remain outside this cohort). The universal discount-rate-evidence gap (§5) remains open and is not closed by this implementation.

---

*This session does not review its own pull request, mark it ready, merge it, or post principal acceptance. Independent exact-head review, any required bounded correction and re-review, and explicit principal acceptance remain required before merge.*
